STOCK TITAN

[Form 4] Arteris, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Arteris, Inc. (AIP) Form 4: Nicholas B. Hawkins, Vice President and Chief Financial Officer, reported a sale of 438 shares of Arteris common stock on 09/02/2025 at a price of $8.9417 per share. The filing states the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units. After the transaction Hawkins beneficially owned 107,558 shares, held directly. The form was signed by an attorney-in-fact on behalf of Hawkins on 09/03/2025.

Arteris, Inc. (AIP) Modulo 4: Nicholas B. Hawkins, Vicepresidente e Chief Financial Officer, ha venduto 438 azioni ordinarie Arteris il 02/09/2025 al prezzo di $8,9417 per azione. La comunicazione specifica che le azioni sono state vendute per coprire l'imposta dovuta dalla liberazione di restricted stock units. Dopo l'operazione Hawkins possedeva per beneficiario 107.558 azioni, detenute direttamente. Il modulo è stato firmato da un procuratore in nome di Hawkins il 03/09/2025.

Arteris, Inc. (AIP) Formulario 4: Nicholas B. Hawkins, vicepresidente y director financiero, informó la venta de 438 acciones ordinarias de Arteris el 02/09/2025 a un precio de $8.9417 por acción. La presentación indica que las acciones se vendieron para cubrir la obligación fiscal derivada del otorgamiento de unidades restringidas. Tras la transacción, Hawkins poseía beneficiariamente 107.558 acciones, en propiedad directa. El formulario fue firmado por un apoderado en representación de Hawkins el 03/09/2025.

Arteris, Inc. (AIP) Form 4: 부사장 겸 최고재무책임자 Nicholas B. Hawkins는 2025-09-02에 Arteris 보통주 438주를 주당 $8.9417에 매도했다고 보고했습니다. 신고서에는 해당 주식이 제한부주식단위(restricted stock units) 해제에 따른 세금 납부를 위해 매도되었다고 적혀 있습니다. 거래 후 Hawkins는 직접 보유하여 실질적으로 107,558주를 보유하고 있었습니다. 해당 서류는 2025-09-03에 Hawkins를 대리하는 법정대리인(변호사)에 의해 서명되었습니다.

Arteris, Inc. (AIP) Formulaire 4 : Nicholas B. Hawkins, vice-président et directeur financier, a déclaré la vente de 438 actions ordinaires Arteris le 02/09/2025 au prix de 8,9417 $ par action. Le dépôt précise que les actions ont été vendues pour couvrir l'impôt dû suite à la libération d'unités d'actions restreintes. Après la transaction, Hawkins détenait bénéficiairement 107 558 actions, en propriété directe. Le formulaire a été signé par un mandataire au nom de Hawkins le 03/09/2025.

Arteris, Inc. (AIP) Formular 4: Nicholas B. Hawkins, Vizepräsident und Chief Financial Officer, meldete den Verkauf von 438 Arteris-Stammaktien am 02.09.2025 zu einem Preis von $8,9417 je Aktie. Die Einreichung gibt an, dass die Aktien verkauft wurden, um die steuerliche Verbindlichkeit infolge der Freigabe von Restricted Stock Units zu begleichen. Nach der Transaktion besaß Hawkins wirtschaftlich 107.558 Aktien, direkt gehalten. Das Formular wurde am 03.09.2025 von einem Bevollmächtigten im Namen von Hawkins unterzeichnet.

Positive
  • Timely disclosure of the transaction consistent with Section 16 reporting requirements
  • Transaction clearly explained as sale to satisfy tax liability from released RSUs, reducing ambiguity
Negative
  • Minor reduction in direct holdings: 438 shares sold, lowering shares held by the reporting person

Insights

TL;DR: Routine tax-related disposition of RSU shares by a named executive; indicates standard equity compensation mechanics and timely disclosure.

The transaction is described as a sale to satisfy tax withholding for released restricted stock units rather than a discretionary investment decision. Such transactions are common when executives receive equity compensation and typically reflect administrative sell-to-cover activity. The filing includes the post-transaction beneficial ownership of 107,558 shares, which helps investors track insider stake dilution and alignment. No other changes to holdings or derivative transactions are reported.

TL;DR: Small-volume insider sale unlikely to be material; it's a tax-withholding sale tied to RSU vesting.

The sale of 438 shares at $8.9417 each generates gross proceeds of approximately $3,915, indicating a limited monetary amount relative to typical executive holdings. Because the filing explicitly ties the sale to tax obligations from RSU release, it should not be interpreted as a signal about the officer’s view on company prospects. The retained stake of 107,558 shares remains as disclosed, providing continuity in ownership data for modeling insider alignment.

Arteris, Inc. (AIP) Modulo 4: Nicholas B. Hawkins, Vicepresidente e Chief Financial Officer, ha venduto 438 azioni ordinarie Arteris il 02/09/2025 al prezzo di $8,9417 per azione. La comunicazione specifica che le azioni sono state vendute per coprire l'imposta dovuta dalla liberazione di restricted stock units. Dopo l'operazione Hawkins possedeva per beneficiario 107.558 azioni, detenute direttamente. Il modulo è stato firmato da un procuratore in nome di Hawkins il 03/09/2025.

Arteris, Inc. (AIP) Formulario 4: Nicholas B. Hawkins, vicepresidente y director financiero, informó la venta de 438 acciones ordinarias de Arteris el 02/09/2025 a un precio de $8.9417 por acción. La presentación indica que las acciones se vendieron para cubrir la obligación fiscal derivada del otorgamiento de unidades restringidas. Tras la transacción, Hawkins poseía beneficiariamente 107.558 acciones, en propiedad directa. El formulario fue firmado por un apoderado en representación de Hawkins el 03/09/2025.

Arteris, Inc. (AIP) Form 4: 부사장 겸 최고재무책임자 Nicholas B. Hawkins는 2025-09-02에 Arteris 보통주 438주를 주당 $8.9417에 매도했다고 보고했습니다. 신고서에는 해당 주식이 제한부주식단위(restricted stock units) 해제에 따른 세금 납부를 위해 매도되었다고 적혀 있습니다. 거래 후 Hawkins는 직접 보유하여 실질적으로 107,558주를 보유하고 있었습니다. 해당 서류는 2025-09-03에 Hawkins를 대리하는 법정대리인(변호사)에 의해 서명되었습니다.

Arteris, Inc. (AIP) Formulaire 4 : Nicholas B. Hawkins, vice-président et directeur financier, a déclaré la vente de 438 actions ordinaires Arteris le 02/09/2025 au prix de 8,9417 $ par action. Le dépôt précise que les actions ont été vendues pour couvrir l'impôt dû suite à la libération d'unités d'actions restreintes. Après la transaction, Hawkins détenait bénéficiairement 107 558 actions, en propriété directe. Le formulaire a été signé par un mandataire au nom de Hawkins le 03/09/2025.

Arteris, Inc. (AIP) Formular 4: Nicholas B. Hawkins, Vizepräsident und Chief Financial Officer, meldete den Verkauf von 438 Arteris-Stammaktien am 02.09.2025 zu einem Preis von $8,9417 je Aktie. Die Einreichung gibt an, dass die Aktien verkauft wurden, um die steuerliche Verbindlichkeit infolge der Freigabe von Restricted Stock Units zu begleichen. Nach der Transaktion besaß Hawkins wirtschaftlich 107.558 Aktien, direkt gehalten. Das Formular wurde am 03.09.2025 von einem Bevollmächtigten im Namen von Hawkins unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hawkins Nicholas B.

(Last) (First) (Middle)
C/O ARTERIS, INC.
900 E. HAMILTON AVE., SUITE 300

(Street)
CAMPBELL CA 95008

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP and Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 S(1) 438 D $8.9417 107,558 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units.
Remarks:
/s/ Paul Alpern, as Attorney-in-Fact for Hawkins Nicholas B. 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Nicholas B. Hawkins report on his Form 4 for Arteris, Inc. (AIP)?

He reported the sale of 438 shares of Arteris common stock on 09/02/2025 at $8.9417 per share to satisfy tax withholding from released RSUs.

How many Arteris (AIP) shares does Hawkins own after the reported transaction?

The filing shows Hawkins beneficially owned 107,558 shares following the transaction.

Why were the shares sold according to the Form 4?

The Form 4 states the shares were sold to satisfy the reporting person’s tax liability arising from the release of restricted stock units.

When was the Form 4 signed and who signed it?

The Form 4 was signed on behalf of Nicholas B. Hawkins by Paul Alpern, as Attorney-in-Fact on 09/03/2025.

Does the Form 4 report any option exercises or derivative transactions for Hawkins?

No. The filing contains only the reported non-derivative sale of common stock; no derivative securities or option exercises are reported.
Arteris, Inc.

NASDAQ:AIP

AIP Rankings

AIP Latest News

AIP Latest SEC Filings

AIP Stock Data

377.03M
29.50M
30.79%
47.8%
2.57%
Semiconductors
Semiconductors & Related Devices
Link
United States
CAMPBELL